Загрузка...
Novel therapeutic strategies in the treatment of triple-negative breast cancer
Triple-negative breast cancer (TNBC) is a heterogeneous subtype of breast cancer that is defined by negative estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) status. Treating patients with TNBC remains clinically challenging, as patients are not...
Сохранить в:
| Опубликовано в: : | Ther Adv Med Oncol |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5502951/ https://ncbi.nlm.nih.gov/pubmed/28717401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834017711380 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|